Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Multiple Sclerosis”

336 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 336 results

Not applicableUnknownNCT04977622
What this trial is testing

Gray Matter Demyelination in Primary Progressive MS at 7T

Who this might be right for
Primary Progressive Multiple Sclerosis
Danish Research Centre for Magnetic Resonance 60
Large-scale testing (Phase 3)Ended earlyNCT04925557
What this trial is testing

Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary-progressive Multiple Sclerosis
State University of New York at Buffalo 8
Early research (Phase 1)Active Not RecruitingNCT06566261
What this trial is testing

ABA-101 in Participants With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Abata Therapeutics 12
Large-scale testing (Phase 3)Temporarily pausedNCT05441488
What this trial is testing

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
AB Science 800
Early research (Phase 1)Looking for participantsNCT07224373
What this trial is testing

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AstraZeneca 24
Not applicableUnknownNCT03787446
What this trial is testing

PET Study in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of British Columbia 9
Not applicableStudy completedNCT04918225
What this trial is testing

Motor Asymmetry in Progressive Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Rennes University Hospital 46
Not applicableStudy completedNCT04545372
What this trial is testing

Aerobic Exercises for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary Progressive
South Valley University 30
Post-approval studies (Phase 4)Study completedNCT02208050
What this trial is testing

The Effectiveness of Fampridine in Improving Upper Limb Function in MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
University College Dublin 64
Testing effectiveness (Phase 2)WithdrawnNCT03696485
What this trial is testing

Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
Stem Cell Medicine Ltd.
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Early research (Phase 1)Ended earlyNCT01144351
What this trial is testing

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 32
Not applicableStudy completedNCT03094364
What this trial is testing

Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisHemiparesis
University of Massachusetts, Lowell 31
Testing effectiveness (Phase 2)Looking for participantsNCT07477639
What this trial is testing

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis (SPMS)Multiple Sclerosis+2 more
Tr1X, Inc. 39
Early research (Phase 1)Study completedNCT03493841
What this trial is testing

Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisProgressive Multiple SclerosisSecondary Progressive Multiple Sclerosis+1 more
Rebecca Spain 20
Large-scale testing (Phase 3)Study completedNCT02290444
What this trial is testing

Effects of Acthar on Recovery From Cognitive Relapses in MS

Who this might be right for
Multiple Sclerosis
State University of New York at Buffalo 64
Not applicableStudy completedNCT03679468
What this trial is testing

Improving Cognition in People With Progressive Multiple Sclerosis Using Aerobic Exercise and Cognitive Rehabilitation

Who this might be right for
Multiple Sclerosis, Primary ProgressiveCognitive Impairment
Sunnybrook Health Sciences Centre 309
Testing effectiveness (Phase 2)Study completedNCT02284568
What this trial is testing

Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

Who this might be right for
Primary Progressive Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 374
Large-scale testing (Phase 3)Ended earlyNCT00870155
What this trial is testing

Patients With Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Eli Lilly and Company 546
Load More Results